AKLRD develops novel solutions for inflammatory diseases with a high unmet need

>300M

Worldwide more than 303 million people are affected by osteoarthritis

NEWS

Personalised Medicine & Disease Modification in OA

Read More

NEWS

How close are disease‐modifying drugs for OA?

Read More

NEWS

Phase II osteoarthritis clinical trial underway

Read More